stock.name

Geron Corp.

GERN

Market Cap$2.16B
Close$

Compare Geron

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Geron Corp.Geron Corp.-11.70%-74%-0.3
marketMarket Avg58.21.29%31%-1
HealthcareHealthcare Avg641.3%15%-0.9
$4.83

Target Price by Analysts

24.9% upsideGeron Target Price DetailsTarget Price
$-0.03

Current Fair Value

100.8% downside

Overvalued by 100.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.16 Billion
Enterprise Value$1.91 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.32
Beta0.0
Outstanding Shares546,873,894
Avg 30 Day Volume11,585,648

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.73
PEG-53.56
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue8052.31
Enterprise Value to EBIT-9.84
Enterprise Value to Net Income-11
Total Debt to Enterprise0.04
Debt to Equity0.33

Revenue Sources

No data

ESG Score

No data

About Geron Corp.

CEO: John Scarlett